Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 10/11/23
Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocksMarket Watch • 09/27/23
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib MonotherapyPRNewsWire • 09/26/23
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business UpdatePRNewsWire • 08/09/23
Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer RelationshipPRNewsWire • 08/07/23
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business UpdatePRNewsWire • 05/04/23
Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal CancerPRNewsWire • 03/28/23
Has Cardiff Oncology (CRDF) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/17/23
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business UpdatePRNewsWire • 03/02/23
Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical OfficerPRNewsWire • 02/02/23
Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology ConferencePRNewsWire • 01/10/23
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business UpdatesPRNewsWire • 11/03/22
Cardiff Oncology: 41% Loss In One Day For A Best-In-Class Colorectal Cancer TreatmentSeeking Alpha • 09/14/22
Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business UpdatesPRNewsWire • 09/12/22
Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022PRNewsWire • 09/10/22
Cardiff Oncology Announces Upcoming Poster Presentations at the ESMO Congress 2022PRNewsWire • 09/06/22